Title(s):
Associate Professor of Oncology
Associate Professor of Dermatology
Associate Professor of Dermatology
Appointment Phone:
410-616-7660
Primary Location:
Johns Hopkins Medicine - Green Spring Station
Expertise:
Cutaneous Oncology, Gastrointestinal Cancers, General Internal Medicine, Immunotherapy, Melanoma, Merkel Cell Carcinoma
Education and Experience
Training
- University of Toledo College of Medicine (Toledo OH)/ (1982)
Residencies
- Cleveland Clinic (Cleveland OH)/ Internal Medicine (1985)
Fellowships
- Cleveland Clinic (Cleveland OH)/ Hematology & Oncology (1989)
Certifications
- Medical Oncology, American Board of Internal Medicine (1989)
- Internal Medicine, American Board of Internal Medicine (1986)
Locations
Johns Hopkins Medicine - Green Spring Station
10753 Falls Road
Pavilion II
Baltimore, MD 21093
Phone: 410-583-2970
Appointment Phone: 410-616-7660
Fax: 410-583-2980
Location Map
Department / Division
- Oncology
Centers/Institutes
Centers / Institutes
- Sidney Kimmel Comprehensive Cancer Center
Bio
Expertise
- Cutaneous Oncology
- Gastrointestinal Cancers
- General Internal Medicine
- Immunotherapy
- Melanoma
- Merkel Cell Carcinoma
Research
Research and Publications
Journal Citations
Lange, J.R.; Fecher, L.; Sharfman, W.H.; Alani, R.M.; Mikkilineni, R.; Topalian, S.L.; Balch, C.M. Melanoma. In: Abeloff MD, A.J., Niederhuber JE, Kastan MB, McKenna WG editor. 4th ed, Abeloffs Clinical Oncology. Philadelphia: Elsevier Inc.; 2008. p. 1229-1252.
Brahmer, J.R.; Drake, C.G.; Wollner, I.; Powderly, J.D.; Picus, J.; Sharfman, W.H.; Stankevich, E.; Pons, A.; Salay, T.M.; McMiller, T.L.; Gilson, M.M.; Wang, C.; Selby, M.; Taube, J.M.; Anders, R.; Chen, L.; Korman, A.J.; Pardoll, D.M.; Lowy, I.; Topalian, S.L. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010 Jul 1;28(19):3167-3175.
Lange, J.R.; Fecher, L.; Sharfman, W.H.; Alani, R.M.; Mikkilineni, R.; Topalian, S.L.; Balch, C.M. Melanoma. In: Abeloff MD, A.J., Niederhuber JE, Kastan MB, McKenna WG editor. 4th ed, Abeloffs Clinical Oncology. Philadelphia: Elsevier Inc.; 2008. p. 1229-1252.
Brahmer, J.R.; Drake, C.G.; Wollner, I.; Powderly, J.D.; Picus, J.; Sharfman, W.H.; Stankevich, E.; Pons, A.; Salay, T.M.; McMiller, T.L.; Gilson, M.M.; Wang, C.; Selby, M.; Taube, J.M.; Anders, R.; Chen, L.; Korman, A.J.; Pardoll, D.M.; Lowy, I.; Topalian, S.L. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010 Jul 1;28(19):3167-3175.
Research Interests
- novel therapies for high risk and advanced melanoma patients
More Info
Languages
- English
Additional Resources
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts